You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Tested Applications | IF, WB |
|---|---|
| Dilution Range | WB: 1:500-2000, IHC-P: 1:50-200 |
| Reactivity | Human |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Rabbit |
| Clonality | Polyclonal |
| Immunogen | Recombinant full length protein of human Chitotriosidase |
| Target | CHIT1 |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Protocol Information
Filter by Applications
Filter by Species
N Przysucha, M Paplińska-Goryca, K Górska, P Misiukiewicz-Stępień, M Mlącki, A Cyran Exploring CHIT1 and YKL-40 in tuberculous pleural effusion: insights and implications researchsquare.com, (2024)
Applications
Reactivity
Sklepkiewicz, Piotr et al. Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis Eur J Pharmacol, 919, 174792 (2022)
B, Dymek et al. Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis Journal of inflammation research, 15, (2022)




